Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

R. Trappe (1) , H. Riess (1) , I. Anagnostopoulos (2) , R. Neuhaus (3) , B. C. Gärtner (4) , H. Pohl (5) , H. P. Müller (5) , S. Jonas (3) , M. Papp-Vary (1) , S. Oertel (6)

1 Department of Hematology and Oncology
2 Department of Pathology
3 Department of General, Visceral, and Transplantation Surgery
4 Institute of Virology
5 Department of Gastroenterology
6 Section Hematology/Oncology

Mots clés: Medicine

R. Trappe, H. Riess, I. Anagnostopoulos, R. Neuhaus, B. C. Gärtner, et al.. Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone. Annals of Hematology, 2008, 88 (2), pp.167-172. ⟨10.1007/s00277-008-0538-0⟩. ⟨hal-00486515⟩